Resumen
Aims: Considerable evidence points to critical roles of intracellular Ca 2+ homeostasis in the modulation and control of autophagic activity. Yet, underlying molecular mechanisms remain unknown. Mutations in the gene (pkd2) encoding polycystin-2 (PC2) are associated with autosomal dominant polycystic kidney disease (ADPKD), the most common inherited nephropathy. PC2 has been associated with impaired Ca 2+ handling in cardiomyocytes and indirect evidence suggests that this protein may be involved in autophagic control. Here, we investigated the role for PC2 as an essential regulator of Ca 2+ homeostasis and autophagy. Methods and results: Activation of autophagic flux triggered by mTOR inhibition either pharmacologically (rapamycin) or by means of nutrient depletion was suppressed in cells depleted of PC2. Moreover, cardiomyocyte-specific PC2 knockout mice (αMhc-cre;Pkd2 F/F mice) manifested impaired autophagic flux in the setting of nutrient deprivation. Stress-induced autophagy was blunted by intracellular Ca 2+ chelation using BAPTA-AM, whereas removal of extracellular Ca 2+ had no effect, pointing to a role of intracellular Ca 2+ homeostasis in stress-induced cardiomyocyte autophagy. To determine the link between stress-induced autophagy and PC2-induced Ca 2+ mobilization, we over-expressed either wild-type PC2 (WT) or a Ca 2+ -channel deficient PC2 mutant (PC2-D509V). PC2 over-expression increased autophagic flux, whereas PC2-D509V expression did not. Importantly, autophagy induction triggered by PC2 over-expression was attenuated by BAPTA-AM, supporting a model of PC2-dependent control of autophagy through intracellular Ca 2+ . Furthermore, PC2 ablation was associated with impaired Ca 2+ handling in cardiomyocytes marked by partial depletion of sarcoplasmic reticulum Ca 2+ stores. Finally, we provide evidence that Ca 2+ -mediated autophagy elicited by PC2 is a mechanism conserved across multiple cell types. Conclusion: Together, this study unveils PC2 as a novel regulator of autophagy acting through control of intracellular Ca 2+ homeostasis.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 110-121 |
Número de páginas | 12 |
Publicación | Journal of Molecular and Cellular Cardiology |
Volumen | 118 |
DOI | |
Estado | Published - may. 2018 |
Financiación
This work was supported by grants from the National Institutes of Health ( HL-120732 , JAH; HL-128215 , JAH; HL-126012 ), American Heart Association ( 14SFRN20510023 , JAH; 14SFRN20670003 ; JAH), Fondation Leducq ( 11CVD04 ), and Cancer Prevention and Research Institute of Texas ( RP110486P3 ); by the P EW Latin American Fellows Program ( 00002991 ) in the Biomedical Science (AC); by the Yale O'Brien Kidney Center ( P30 DK079310 ; SS) by Fondo Nacional de Desarrollo Científico y Tecnológico , FONDECYT ( 1171075 to AC, 11150282 to VP and 1161156 to SL); by FONDAP ( 1513001 1 to AC, SL, VP, ZP, and JAH) and PAI Insertion Program Grant ( 79150007 to VP) from the Comisión Nacional de Investigación Científica y Tecnológica (CONICYT), Santiago, Chile. F.A. and V.P. were supported by an American Heart Association postdoctoral fellowship ( 16POST30680016 to F.A. and 13POST16520009 to V.P.).
Financiadores | Número del financiador |
---|---|
Biomedical Science | |
Yale O'Brien Kidney Center | P30 DK079310 |
National Institutes of Health | HL-128215, HL-120732, HL-126012 |
American Heart Association | 14SFRN20510023, 14SFRN20670003 |
Cancer Prevention and Research Institute of Texas | RP110486P3, 00002991 |
Fondation Leducq | 11CVD04 |
Comisión Nacional de Investigación Científica y Tecnológica | 16POST30680016, 13POST16520009 |
Fondo Nacional de Desarrollo Científico y Tecnológico | 1171075, 11150282, 1161156 |
Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias | 1513001 1, 79150007 |
ASJC Scopus Subject Areas
- Molecular Biology
- Cardiology and Cardiovascular Medicine